These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19545213)

  • 1. Dietary regulation of P-gp function and expression.
    Zhang W; Han Y; Lim SL; Lim LY
    Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):789-801. PubMed ID: 19545213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).
    Marchetti S; Mazzanti R; Beijnen JH; Schellens JH
    Oncologist; 2007 Aug; 12(8):927-41. PubMed ID: 17766652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues.
    Matheny CJ; Ali RY; Yang X; Pollack GM
    Drug Metab Dispos; 2004 Sep; 32(9):1008-14. PubMed ID: 15319343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of P-glycoprotein in statin drug interactions.
    Holtzman CW; Wiggins BS; Spinler SA
    Pharmacotherapy; 2006 Nov; 26(11):1601-7. PubMed ID: 17064205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression.
    Han Y; Chin Tan TM; Lim LY
    Toxicol Appl Pharmacol; 2008 Aug; 230(3):283-9. PubMed ID: 18417181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein related drug interactions: clinical importance and a consideration of disease states.
    Lee CA; Cook JA; Reyner EL; Smith DA
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):603-19. PubMed ID: 20397967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction.
    Sun J; He ZG; Cheng G; Wang SJ; Hao XH; Zou MJ
    Med Sci Monit; 2004 Jan; 10(1):RA5-14. PubMed ID: 14704647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein in the placenta: expression, localization, regulation and function.
    Ceckova-Novotna M; Pavek P; Staud F
    Reprod Toxicol; 2006 Oct; 22(3):400-10. PubMed ID: 16563694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential for interaction of kava and St. John's wort with drugs.
    Singh YN
    J Ethnopharmacol; 2005 Aug; 100(1-2):108-13. PubMed ID: 16005588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats.
    Zhang W; Tan TM; Lim LY
    Drug Metab Dispos; 2007 Jan; 35(1):110-5. PubMed ID: 17050652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of St John's wort on the pharmacokinetics of fexofenadine.
    Wang Z; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2002 Jun; 71(6):414-20. PubMed ID: 12087344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of capsaicin on P-gp function and expression in Caco-2 cells.
    Han Y; Tan TM; Lim LY
    Biochem Pharmacol; 2006 Jun; 71(12):1727-34. PubMed ID: 16674925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
    Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
    Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging significance of P-glycoprotein in understanding drug disposition and drug interactions in psychopharmacology.
    Carson SW; Ousmanou AD; Hoyler SL
    Psychopharmacol Bull; 2002; 36(1):67-81. PubMed ID: 12397848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effects of Mangifera indica and polyphenols derived on ABCB1/P-glycoprotein activity.
    Chieli E; Romiti N; Rodeiro I; Garrido G
    Food Chem Toxicol; 2009 Nov; 47(11):2703-10. PubMed ID: 19632288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of food and dietary supplements with drug metabolising cytochrome P450 enzymes.
    Nekvindová J; Anzenbacher P
    Ceska Slov Farm; 2007 Jul; 56(4):165-73. PubMed ID: 17969314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the expression and function of P-glycoprotein in rats: drug treatments and diseased states.
    Murakami T; Yumoto R; Nagai J; Takano M
    Pharmazie; 2002 Feb; 57(2):102-7. PubMed ID: 11878184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.